BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2958791)

  • 1. Use of 4-methylumbelliferyl-6-sulpho-2-acetamido-2-deoxy-beta- D-glucopyranoside for prenatal diagnosis of Tay-Sachs disease using chorionic villi.
    Grebner EE; Wenger DA
    Prenat Diagn; 1987 Jul; 7(6):419-23. PubMed ID: 2958791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First trimester prenatal diagnosis of Tay-Sachs disease using the sulfated synthetic substrate for hexosaminidase A.
    Callahan JW; Archibald A; Skomorowski MA; Shuman C; Clarke JT
    Clin Biochem; 1990 Dec; 23(6):533-6. PubMed ID: 2149678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of 4-methylumbelliferyl-6-sulfo-2-acetamido-2-deoxy-beta-D-glucopyrano sid e for the diagnosis of GM2 gangliosidoses in leukocytes.
    Inui K; Wenger DA
    Clin Genet; 1984 Oct; 26(4):318-21. PubMed ID: 6238730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid detection of fetal Mendelian disorders: Tay-Sachs disease.
    Guetta E; Peleg L
    Methods Mol Biol; 2008; 444():147-59. PubMed ID: 18425478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal diagnosis for Tay-Sachs disease using chorionic villus sampling.
    Grebner EE; Jackson LG
    Prenat Diagn; 1985; 5(5):313-20. PubMed ID: 2933645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First-trimester prenatal diagnosis of Tay-Sachs disease.
    Grabowski GA; Kruse JR; Goldberg JD; Chockkalingam K; Gordon RE; Blakemore KJ; Mahoney MJ; Desnick RJ
    Am J Hum Genet; 1984 Nov; 36(6):1369-78. PubMed ID: 6240199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prenatal Diagnosis of Tay-Sachs Disease.
    Zhang J; Chen H; Kornreich R; Yu C
    Methods Mol Biol; 2019; 1885():233-250. PubMed ID: 30506202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and carrier detection of Tay-Sachs disease: direct determination of hexosaminidase A using 4-methylumbelliferyl derivatives of beta-N-acetylglucosamine-6-sulfate and beta-N-acetylgalactosamine-6-sulfate.
    Ben-Yoseph Y; Reid JE; Shapiro B; Nadler HL
    Am J Hum Genet; 1985 Jul; 37(4):733-40. PubMed ID: 9556661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tay-Sachs disease heterozygote detection: use of a centrifugal analyser for automation of hexosaminidase assays with two different artificial substrates.
    Landels EC; Ellis IH; Bobrow M; Fensom AH
    J Med Genet; 1991 Feb; 28(2):101-9. PubMed ID: 1825851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prenatal Tay-Sachs diagnosis by chorionic villi sampling.
    Lancet; 1983 Jul; 2(8344):286-7. PubMed ID: 6135112
    [No Abstract]   [Full Text] [Related]  

  • 11. Enzyme studies in GM2 gangliosidiosis, and their application in prenatal diagnosis.
    Kaur M; Verma IC
    Indian J Pediatr; 1995; 62(4):485-9. PubMed ID: 10829910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of Tay-Sachs disease carriers among individuals with thermolabile hexosaminidase B.
    Peleg L; Goldman B
    Eur J Clin Chem Clin Biochem; 1994 Feb; 32(2):65-9. PubMed ID: 8003579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal diagnosis of GM2 gangliosidoses using a fluorogenic sulfated substrate.
    Inui K; Wenger DA; Furukawa M; Suehara N; Yutaka Y; Okada S; Tanizawa O; Yabuuchi H
    Clin Chim Acta; 1986 Jan; 154(2):145-50. PubMed ID: 3955840
    [No Abstract]   [Full Text] [Related]  

  • 14. Synthesis of 4-methylumbelliferyl-beta-D-N-acetylglucosamine-6-sulfate and its use in classification of GM2 gangliosidosis genotypes.
    Bayleran J; Hechtman P; Saray W
    Clin Chim Acta; 1984 Nov; 143(2):73-89. PubMed ID: 6239713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 4-Methylumbelliferyl alpha-N-acetylglucosaminidase activity for diagnosis of Sanfilippo B disease.
    Marsh J; Fensom AH
    Clin Genet; 1985 Mar; 27(3):258-62. PubMed ID: 3921297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenatal diagnosis of GM2 gangliosidosis with high residual hexosaminidase A activity (variant B1; pseudo AB variant).
    Conzelmann E; Nehrkorn H; Kytzia HJ; Sandhoff K; Macek M; Lehovský M; Elleder M; Jirásek A; Kobilková J
    Pediatr Res; 1985 Nov; 19(11):1220-4. PubMed ID: 2933632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prenatal diagnosis of Tay-Sachs disease. Reflectometry of hexosaminidase A, B, and C/S bands on zymograms.
    Kustermann-Kuhn B; Harzer K
    Hum Genet; 1983; 65(2):172-5. PubMed ID: 6228513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In situ assessment of beta-hexosaminidase activity.
    Lacorazza HD; Jendoubi M
    Biotechniques; 1995 Sep; 19(3):434-40. PubMed ID: 7495557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late onset GM2 gangliosidosis: an alpha-locus genetic compound with near normal hexosaminidase activity.
    Charrow J; Inui K; Wenger DA
    Clin Genet; 1985 Jan; 27(1):78-84. PubMed ID: 3156697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tay-Sachs disease: one-step assay of beta-N-acetylhexosaminidase in serum with a sulphated chromogenic substrate.
    Fuchs W; Navon R; Kaback MM; Kresse H
    Clin Chim Acta; 1983 Oct; 133(3):253-61. PubMed ID: 6226458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.